Department of Clinical Science, Department of Medicine, University of Bergen, N-5021 Bergen, Norway
Search for other papers by Paal Methlie in
Google Scholar
PubMed
Search for other papers by Steinar Hustad in
Google Scholar
PubMed
Search for other papers by Ralf Kellman in
Google Scholar
PubMed
Search for other papers by Bjørg Almås in
Google Scholar
PubMed
Search for other papers by Martina M Erichsen in
Google Scholar
PubMed
Department of Clinical Science, Department of Medicine, University of Bergen, N-5021 Bergen, Norway
Search for other papers by Eystein S Husebye in
Google Scholar
PubMed
Department of Clinical Science, Department of Medicine, University of Bergen, N-5021 Bergen, Norway
Search for other papers by Kristian Løvås in
Google Scholar
PubMed
's syndrome (CS) and congenital adrenal hyperplasia, male hypogonadism and female hyperandrogenism. Although immunoassays have largely been used to measure steroid hormones, over the last decade, mass spectrometry (MS) has increasingly been adopted as it
Princess Máxima Center for Pediatric Oncology, AB Utrecht, The Netherlands
Search for other papers by Ichelle Maa van Roessel in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, AB Utrecht, The Netherlands
Search for other papers by Boudewijn Bakker in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, AB Utrecht, The Netherlands
Search for other papers by Hanneke M van Santen in
Google Scholar
PubMed
Search for other papers by Wassim Chemaitilly in
Google Scholar
PubMed
cancer, may be influenced by sex hormones ( 48 , 49 , 50 ). This raises the question whether cancer or brain tumors diagnosed during childhood may be influenced by sex steroids, during treatment or after achieving complete remission, and whether sex
Search for other papers by Lesley A Hill in
Google Scholar
PubMed
Search for other papers by Zeynep Sumer-Bayraktar in
Google Scholar
PubMed
Search for other papers by John G Lewis in
Google Scholar
PubMed
Search for other papers by Eva Morava in
Google Scholar
PubMed
Search for other papers by Morten Thaysen-Andersen in
Google Scholar
PubMed
Search for other papers by Geoffrey L Hammond in
Google Scholar
PubMed
manuscript for publication. Acknowledgement The authors wish to thank Caroline Underhill for technical assistance. References 1 Hammond GL . Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action . Journal of
Search for other papers by Lachlan Angus in
Google Scholar
PubMed
Search for other papers by Shalem Leemaqz in
Google Scholar
PubMed
Search for other papers by Olivia Ooi in
Google Scholar
PubMed
Search for other papers by Pauline Cundill in
Google Scholar
PubMed
Search for other papers by Nicholas Silberstein in
Google Scholar
PubMed
Search for other papers by Peter Locke in
Google Scholar
PubMed
Search for other papers by Jeffrey D Zajac in
Google Scholar
PubMed
Search for other papers by Ada S Cheung in
Google Scholar
PubMed
oestradiol as feminising gender-affirming hormone therapy ( 3 ). Goals of therapy are generally to increase serum oestradiol concentrations and lower serum total testosterone concentrations to achieve sex steroid concentrations in the female reference range
Search for other papers by I Savchuk in
Google Scholar
PubMed
Search for other papers by M L Morvan in
Google Scholar
PubMed
Search for other papers by J P Antignac in
Google Scholar
PubMed
Search for other papers by K Gemzell-Danielsson in
Google Scholar
PubMed
Search for other papers by B Le Bizec in
Google Scholar
PubMed
Search for other papers by O Söder in
Google Scholar
PubMed
Search for other papers by K Svechnikov in
Google Scholar
PubMed
Introduction Steroid hormones produced by the human fetal adrenal glands (HFA) have been proposed to regulate intrauterine homeostasis and the maturation of certain organs required for extrauterine life ( 1 ). In this case, appropriate
National Hospital for Neurology and Neurosurgery, London, UK
Search for other papers by Stephanie E Baldeweg in
Google Scholar
PubMed
Search for other papers by Mark Vanderpump in
Google Scholar
PubMed
Search for other papers by Will Drake in
Google Scholar
PubMed
Search for other papers by Narendra Reddy in
Google Scholar
PubMed
Search for other papers by Andrew Markey in
Google Scholar
PubMed
National Hospital for Neurology and Neurosurgery, London, UK
Search for other papers by Gordon T Plant in
Google Scholar
PubMed
Search for other papers by Michael Powell in
Google Scholar
PubMed
Search for other papers by Saurabh Sinha in
Google Scholar
PubMed
Search for other papers by John Wass in
Google Scholar
PubMed
Search for other papers by the Society for Endocrinology Clinical Committee in
Google Scholar
PubMed
function tests, clotting profile Indications for empirical steroid therapy in patients with pituitary apoplexy are haemodynamic instability, altered consciousness level, reduced visual acuity and severe visual field defects. Steroid replacement is
Search for other papers by Lauren R Cirrincione in
Google Scholar
PubMed
Search for other papers by Bridgit O Crews in
Google Scholar
PubMed
Search for other papers by Jane A Dickerson in
Google Scholar
PubMed
Search for other papers by Matthew D Krasowski in
Google Scholar
PubMed
Search for other papers by Jessica Rongitsch in
Google Scholar
PubMed
Search for other papers by Katherine L Imborek in
Google Scholar
PubMed
CUNY Graduate School of Public Health and Health Policy, New York, New York, USA
Search for other papers by Zil Goldstein in
Google Scholar
PubMed
Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
Search for other papers by Dina N Greene in
Google Scholar
PubMed
Introduction Estradiol (17β-estradiol) is a natural sex steroid available in several exogenous preparations. The Endocrine Society recommended high-dose exogenous estradiol treatment as one part of feminizing hormone therapy for transgender
Search for other papers by Yael Sofer in
Google Scholar
PubMed
Search for other papers by Nava Nevo in
Google Scholar
PubMed
Search for other papers by Michal Vechoropoulos in
Google Scholar
PubMed
Search for other papers by Gabi Shefer in
Google Scholar
PubMed
Search for other papers by Etty Osher in
Google Scholar
PubMed
Search for other papers by Nathan Landis in
Google Scholar
PubMed
Search for other papers by Karen Tordjman in
Google Scholar
PubMed
Search for other papers by Geoffrey L Hammond in
Google Scholar
PubMed
Search for other papers by Naftali Stern in
Google Scholar
PubMed
Wellons M Vaidya D Lehtimäki T Keildson S Lunetta KL He C Fornage M Lagou V A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone
Alfred Health, Melbourne, Victoria, Australia
Search for other papers by Pravik Solanki in
Google Scholar
PubMed
Department of General Practice, Melbourne Medical School, The University of Melbourne, Victoria, Australia
Search for other papers by Beng Eu in
Google Scholar
PubMed
Search for other papers by Jeremy Smith in
Google Scholar
PubMed
Search for other papers by Carolyn Allan in
Google Scholar
PubMed
Search for other papers by Kevin Lee in
Google Scholar
PubMed
chloroquine (3 subjects) was continued throughout the study period. AAS, anabolic androgenic steroid; CI, confidence interval; FSH, follicle-stimulating hormone; IM, intramuscular; LH, luteinising hormone; PO, oral; RR, relative risk. To aid
Search for other papers by Veronica Kieffer in
Google Scholar
PubMed
Search for other papers by Kate Davies in
Google Scholar
PubMed
Search for other papers by Christine Gibson in
Google Scholar
PubMed
Search for other papers by Morag Middleton in
Google Scholar
PubMed
Search for other papers by Jean Munday in
Google Scholar
PubMed
Search for other papers by Shashana Shalet in
Google Scholar
PubMed
Search for other papers by Lisa Shepherd in
Google Scholar
PubMed
Search for other papers by Phillip Yeoh in
Google Scholar
PubMed
consultancy • Supports, teaches and assesses junior staff a Endocrine dynamic function testing competency. b Steroid replacement therapy for disorders of the pituitary and adrenal glands competency. c Growth hormone deficiency competency. d Hypogonadism